CELLULAR NANOPARTICLE (CNP) Trademark
Trademark Overview
On Thursday, May 26, 2022, a trademark application was filed for CELLULAR NANOPARTICLE (CNP) with the United States Patent and Trademark Office. The USPTO has given the CELLULAR NANOPARTICLE (CNP) trademark a serial number of 97430828. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, January 11, 2024. This trademark is owned by Arytha Biosciences, LLC. The CELLULAR NANOPARTICLE (CNP) trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, cell membrane-coated nanoparticles used as drug delivery vehicles for targeted delivery of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, cell membrane-coated nanoparticles used as therapeutic pharmaceuticals for the treatment of infectious disease, cancer, inflammatory disease, cardiovascular disease, and autoimmune disease
General Information
| Serial Number | 97430828 |
| Word Mark | CELLULAR NANOPARTICLE (CNP) |
| Filing Date | Thursday, May 26, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, January 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 13, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, cell membrane-coated nanoparticles used as drug delivery vehicles for targeted delivery of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, cell membrane-coated nanoparticles used as therapeutic pharmaceuticals for the treatment of infectious disease, cancer, inflammatory disease, cardiovascular disease, and autoimmune disease |
| Disclaimer with Predetermined Text | "CELLULAR NANOPARTICLE" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 2, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Arytha Biosciences, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | San Diego, CA 92121 |
| Party Name | Arytha Biosciences, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | San Diego, CA 92121 |
Trademark Events
| Event Date | Event Description |
| Saturday, January 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 11, 2024 | SOU EXTENSION 1 GRANTED |
| Thursday, January 11, 2024 | SOU EXTENSION 1 FILED |
| Thursday, January 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 8, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 13, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 13, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 24, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 9, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, May 8, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, May 7, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, May 7, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 20, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, March 20, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, March 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 20, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, March 20, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 14, 2023 | ASSIGNED TO EXAMINER |
| Thursday, June 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 30, 2022 | NEW APPLICATION ENTERED |
